Stuart Chaussee & Associates, Inc. Medtronic PLC Transaction History

Stuart Chaussee & Associates, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 12, 2022	SELL	$100.58 - $112.38 $6,638 - $7,417	-66 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$111.18 - $119.74 $7,337 - $7,902	66 New	66 $8,000
Q1 2020 May 14, 2020	SELL	$72.92 - $121.3 $18,230 - $30,325	-250 Closed	0 $0
Q2 2019 Aug 08, 2019	SELL	$84.15 - $99.38 $23,141 - $27,329	-275 Reduced 52.38%	250 $24,000
Q1 2019 May 08, 2019	BUY	$82.45 - $93.79 $43,286 - $49,239	525 New	525 $48,000

2,288

1.02B

8.05M

7.19M

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $108B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

Get notified when there are updates to the investment portfolio of Stuart Chaussee & Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Stuart Chaussee & Associates, Inc. with notifications on news.